(CercleFinance.com) – Crossject announces that it has improved its Gaïa rating in terms of ESG performance, with a score of 73/100 this year compared to 60 in 2022 and 46 in 2021, showing its commitment to sustainable development and business practices responsible’.
This ranking, whose data was compiled by EthiFinance ESG Ratings, demonstrates progress by the pharmaceutical company in the four areas concerned: governance, social, environment and external stakeholders.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
